Glanbia poised for growth through American acquisition
Glanbia is buoyant after another year of strong growth and can make more moves in the growing performance nutrition market, writes Michael Murray.
CytoSport, the US-based sports nutrition business, remains a potential takeover target for Glanbia as the bidding process for the US company remains a work in progress.
Following its results announcement last week Glanbia group managing director SiobhÃ¡n Talbot said that any decision to raise new equity would be ''event driven. This followed reports - in circulation since last summer - that the performance nutrition and ingredients group is on a shortlist of potential buyers for...
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply